Laddar...
Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease
OBJECTIVE: To determine the effect of Vildagliptin in non-alcoholic, fatty liver disease patients with dyslipidemia. METHODS: A randomized placebo controlled trial was conducted at outpatient clinic of Medical Unit-I of Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, in which fifty eight pati...
Sparad:
| I publikationen: | Pak J Med Sci |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Professional Medical Publications
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5216289/ https://ncbi.nlm.nih.gov/pubmed/28083033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12669/pjms.326.11133 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|